Scinovex
articleTop 1% cited

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)

The Lancet · 1996 · Vol. 348(9038) · pp. 1329–1339
Antiplatelet Therapy and Cardiovascular DiseasesVenous Thromboembolism Diagnosis and ManagementAtrial Fibrillation Management and OutcomesClopidogrelMedicineAspirinTiclopidineInternal medicineMyocardial infarctionStroke (engine)Relative riskThienopyridinePopulation

MeSH terms

ClopidogrelAdultArteriosclerosisAspirinBrain IschemiaDouble-Blind MethodFemaleFollow-Up StudiesHemorrhageHumansMalePlatelet Aggregation InhibitorsTiclopidineCohort StudiesPeripheral Vascular Diseases

Funding

  • Bristol-Myers Squibb
  • Sanofi
Citations
6,493
FWCI
78.77
field-weighted impact
References
15
Percentile
100%
vs. same field & year
Citations per year
References
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.